HK1016897A1 - Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities - Google Patents

Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Info

Publication number
HK1016897A1
HK1016897A1 HK99102199A HK99102199A HK1016897A1 HK 1016897 A1 HK1016897 A1 HK 1016897A1 HK 99102199 A HK99102199 A HK 99102199A HK 99102199 A HK99102199 A HK 99102199A HK 1016897 A1 HK1016897 A1 HK 1016897A1
Authority
HK
Hong Kong
Prior art keywords
myogenic cells
perceptive
abnormalities
peptide
relieving pain
Prior art date
Application number
HK99102199A
Other languages
English (en)
Inventor
Peter K Law
Original Assignee
Cell Therapy Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy Res Foundation filed Critical Cell Therapy Res Foundation
Publication of HK1016897A1 publication Critical patent/HK1016897A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK99102199A 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities HK1016897A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5519997P 1997-08-11 1997-08-11

Publications (1)

Publication Number Publication Date
HK1016897A1 true HK1016897A1 (en) 1999-11-12

Family

ID=21996302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102199A HK1016897A1 (en) 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Country Status (7)

Country Link
US (1) US7166279B2 (fr)
EP (1) EP0898967B1 (fr)
JP (1) JPH11147829A (fr)
AT (1) ATE241992T1 (fr)
CA (1) CA2225185A1 (fr)
DE (1) DE69815230T2 (fr)
HK (1) HK1016897A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003505475A (ja) 1999-07-23 2003-02-12 ダイアクリン インク 筋細胞、及び心臓修復におけるそれらの利用
ATE397087T1 (de) * 2000-08-08 2008-06-15 Mgvs Ltd Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese
IL161862A0 (en) * 2001-11-08 2005-11-20 Univ California Methods and compositions for correction of cardiac conduction disturbances
JP4549609B2 (ja) * 2002-04-11 2010-09-22 エスエス製薬株式会社 被覆固形催眠製剤
AU2003239418B2 (en) * 2002-05-08 2008-01-31 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US6932804B2 (en) * 2003-01-21 2005-08-23 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7317950B2 (en) * 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent
EP1740198A4 (fr) * 2004-04-26 2009-03-04 Immuneregen Biosciences Inc Effets anti-age de la substance p
US8889122B2 (en) 2005-05-09 2014-11-18 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
US20090017080A1 (en) * 2007-03-15 2009-01-15 Paul Robert Tanner Personal care kit having skin care compositions with a readily perceptible difference
WO2008157348A1 (fr) * 2007-06-13 2008-12-24 The Procter & Gamble Company Dispositif de traitement de la peau
EP2296594A1 (fr) * 2008-05-15 2011-03-23 Wyeth LLC Procédé d application d un soin de la peau
US20100224205A1 (en) * 2008-12-09 2010-09-09 Shekhar Mitra Device and methods for modifying keratinous surfaces
CN106175030A (zh) 2009-01-16 2016-12-07 宝洁公司 改变角质表面的设备和方法
US20150050300A1 (en) 2013-08-16 2015-02-19 Peter K. Law Disease prevention and alleviation by human myoblast transplantation
JP6633001B2 (ja) 2014-06-13 2020-01-22 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 角質表面を改質するための装置及び方法
EP3155801A2 (fr) 2014-06-13 2017-04-19 The Procter & Gamble Company Appareil et procédés de modification de surface kératinique
EP3154392B1 (fr) 2014-06-13 2020-03-18 The Procter and Gamble Company Cartouches pour le dépôt de compositions de traitement sur des surfaces kératiniques
US10518291B2 (en) 2014-06-13 2019-12-31 The Procter & Gamble Company Device and methods for modifying surfaces
CN106456005B (zh) 2014-06-13 2020-12-08 宝洁公司 用于使角质表面改性的设备和方法
US10156036B2 (en) 2014-06-13 2018-12-18 The Procter & Gamble Company Device and methods for applying compositions to fabric surfaces
WO2015191830A2 (fr) 2014-06-13 2015-12-17 The Procter & Gamble Company Composition, appareil et procédés de traitement pour la modification de surfaces kératiniques
US20160114349A1 (en) 2014-06-13 2016-04-28 The Procter & Gamble Company Device and methods for depositing materials on hard surfaces
WO2015191821A2 (fr) 2014-06-13 2015-12-17 The Procter & Gamble Company Appareil et procédés de modification de surface kératiniques
US10314378B2 (en) 2014-07-25 2019-06-11 The Procter & Gamble Company Cartridge assembly for a dispensing device
US9955769B2 (en) 2014-07-25 2018-05-01 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
US9949552B2 (en) 2014-07-25 2018-04-24 The Procter & Gamble Company Handheld treatment apparatus for modifying keratinous surfaces
US11083880B2 (en) 2014-07-25 2021-08-10 The Procter & Gamble Company Angled cartridge assembly for a dispensing device
US10188193B2 (en) 2014-07-25 2019-01-29 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
JP6878314B2 (ja) 2015-06-11 2021-05-26 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 表面に組成物を塗布するための装置及び方法
US9962532B2 (en) 2015-06-11 2018-05-08 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
US11116302B2 (en) 2015-06-11 2021-09-14 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
US9949547B2 (en) 2015-06-11 2018-04-24 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
US10166799B2 (en) 2015-12-07 2019-01-01 The Procter & Gamble Company Service stations for handheld fluid jet apparatuses
US10391042B2 (en) 2015-12-07 2019-08-27 The Procter & Gamble Company Treatment compositions, apparatus and methods for modifying keratinous surfaces
US9616668B1 (en) 2015-12-07 2017-04-11 The Procter & Gamble Company Servicing cassettes for handheld fluid jet apparatuses for use in modifying surfaces
EP3638107B1 (fr) 2017-06-16 2021-07-21 The Procter & Gamble Company Dispositif de soins personnels avec retour sonore
CA3064495C (fr) 2017-06-16 2022-08-30 The Procter & Gamble Company Methode de maquillage colorimetrique assiste par ordinateur visant a camoufler des variations de couleur de la peau
US11090238B2 (en) 2017-06-16 2021-08-17 The Procter & Gamble Company Array of cosmetic compositions for camouflaging tonal imperfections
WO2021089162A1 (fr) 2019-11-07 2021-05-14 L'oreal Dispositif de microdermabrasion pour colorer la peau
WO2023102287A1 (fr) 2021-12-03 2023-06-08 The Procter & Gamble Company Dispositif de soins personnels avec retour sonore

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE77033B1 (en) * 1989-08-16 1997-11-19 Univ Tulane Substance P antagonists
WO1992016547A1 (fr) * 1991-03-15 1992-10-01 The Children's Medical Center Corporation Controle des reponses a mediation par recepteurs nk-1 et diagnostiques associees
SG74036A1 (en) * 1994-12-13 2000-07-18 Peter K Law Instrument for cell culture

Also Published As

Publication number Publication date
CA2225185A1 (fr) 1999-02-11
US7166279B2 (en) 2007-01-23
EP0898967A1 (fr) 1999-03-03
DE69815230D1 (de) 2003-07-10
US20020044925A1 (en) 2002-04-18
EP0898967B1 (fr) 2003-06-04
JPH11147829A (ja) 1999-06-02
DE69815230T2 (de) 2004-05-06
ATE241992T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
HK1016897A1 (en) Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities
NZ505011A (en) Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
US6895271B2 (en) Iontophoretic drug delivery electrodes and method
GB2269750B (en) Electrical stimulation for treatment of incontinence and other neuro-muscular disorders
AU3632593A (en) Drug delivery devices
DE69112533D1 (de) Einpflanzbares iontophoretisches Abgabesystem.
ATE223176T1 (de) Herzschrittmacher mit elektrode und integriertem sauerstoff-fühler
HK1030853A1 (en) Transdermal therapeutic device with capsaicin and capsaicin analogs
ES2161246T3 (es) Factor transformante de crecimiento alfa h1.
Wheatley et al. A comparison of intact and in-vitro locomotion in an adult amphibian
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
HUT53816A (en) Method for elaborating therapeutical system feeding the agent gradually through the skin
AU5732190A (en) Glycoprotein hormone receptor molecules
MY110263A (en) Reservoir for controlled active substance delivery, apparatus containing the same, as well as method for its manufacture and use of the apparatus.
PT781095E (pt) Celulas contendo receptores chamariz cd4 e moleculas e metodos com elas relacionados
CA2343893C (fr) Electrodes pour administration de medicaments par ionophorese
IL136807A0 (en) Topical carbamazepine formulation and methods of use
CN2164852Y (zh) 全息胚穴位电极带
Wakelee-Lynch Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy
Barreiro et al. Treatment of postoperative pain for burn patients with intravenous analgesia in continuous perfusion using elastomeric infusors
Disselhoff Transcutaneous electrical nerve stimulation (TENS) in neuropathic pain
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
Qiang et al. Effect of auriculoacupuncture on life quality of patients with malignant tumors
Weaver Electroporation of Bacteria and Yeast: An Experimental Study of Molecular Transport
EP1839667A3 (fr) Thérapie de gène à base de cellules pour le système pulmonaire

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: PETER KOI LAW

Free format text: FORMER OWNER(S): CELL THERAPY RESEARCH FOUNDATION

PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110407